Samrat Pharmachem Limited (BSE: 530125)
Materials · Chemicals · IN
Rs242.70
+4.97% today · -23.6% 1Y
Samrat Pharmachem Limited (BSE: 530125) operates in the Chemicals industry within the Materials sector. The company is valued at $7.84M.
Over the last twelve months the share price has lost 23.6%, trading between 190.00 and 333.00.
Tweenvest scores Samrat Pharmachem Limited across four factors: quality 64/100, value 81/100, growth 0/100, dividend 7/100. Its strongest factor is value.
530125 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.84M
- Revenue (TTM)
- $31.08M
- P/E
- —
- EPS
- -7.15
- Dividend yield
- 0.41%
- Beta (5Y)
- -0.18
- 52-week high
- Rs333.00
- 52-week low
- Rs190.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.09M
- Employees
- —
- Next earnings
- —
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Linde plcNasdaqGS: LIN | $224.76B | $487.57 | +1.30% |
| L'Air Liquide S.A.ENXTPA: AI | $124.17B | €167.12 | -0.16% |
| The Sherwin-Williams CompanyNYSE: SHW | $83.64B | $346.59 | -0.09% |
| Ecolab Inc.NYSE: ECL | $78.95B | $281.63 | +0.05% |
| Shin-Etsu Chemical Co., Ltd.TSE: 4063 | $70.78B | ¥6,051.00 | -1.79% |
| Air Products and Chemicals, Inc.NYSE: APD | $67.94B | $305.10 | +1.59% |
| Corteva, Inc.NYSE: CTVA | $54.57B | $81.79 | +2.93% |
| BASF SEXTRA: BAS | $51.93B | €51.67 | +0.33% |
Figures last refreshed Aug 18, 2026.